EPHA2 and cancer: EphA2 overall effect in cancer cells derives from a fine balance between the mainly antioncogenic, ephrin ligand-dependent canonical pathway and the uncanonical pathway that does not rely on ephrin ligand binding and is mostly considered pro-oncogenic [18,19].